Rankings
▼
Calendar
INSM FY 2022 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena
INSM
Insmed Incorporated
$31B
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$245M
+30.2% YoY
Gross Profit
$190M
77.5% margin
Operating Income
-$457M
-186.4% margin
Net Income
-$482M
-196.3% margin
EPS (Diluted)
$-3.91
Cash Flow
Operating Cash Flow
-$400M
Free Cash Flow
-$410M
Stock-Based Comp.
$58M
Balance Sheet
Total Assets
$1.7B
Total Liabilities
$1.6B
Stockholders' Equity
$88M
Cash & Equivalents
$1.1B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$245M
$188M
+30.2%
Gross Profit
$190M
$144M
+31.8%
Operating Income
-$457M
-$375M
-21.9%
Net Income
-$482M
-$435M
-10.8%
← Q4 2021
All Quarters
Q1 2022 →